Home・Aandelen Lijst・Humana Inc

Humana Inc

Gesloten

SectorGezondheidszorg

382.79 -0.49

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

380

Max

388.6

Belangrijke statistieken
By Trading Economics
Inkomsten	-491M 693M
Verkoop	1.2B 41B
K/W Sectorgemiddelde	36.353 57.002
EPS	7.61
Dividendrendement	0.92
Winstmarge	1.696
Werknemers	67,060
EBITDA	-658M 1.3B

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+11.85% upside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	0.92% 2.22%
Volgende Winsten	4 nov 2026
Volgende dividenddatum	30 okt 2026
Volgende Ex Dividend datum	25 sep 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-427M 46B
Vorige openingsprijs	383.28
Vorige sluitingsprijs	382.79

Nieuwssentiment

By Acuity

28%

72%

86 / 340 Rangschikking in Healthcare

Humana Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 aug 2026, 19:46 UTC

Humana Inc shares are higher today, reflecting a broader positive market trend despite recent negative sentiment following a decline in U.S. retail sales.

12 aug 2026, 20:01 UTC

Humana Inc shares are higher during Wednesday's session, continuing an upward trend since Tuesday. The move occurs amid mixed macroeconomic signals and geopolitical tensions.

10 aug 2026, 19:16 UTC

News

Humana shares advance as JPMorgan raises price target to $393.

7 aug 2026, 20:03 UTC

Humana Inc shares are higher today, continuing strong momentum from recent sessions. No specific company news was identified to explain this price action.

6 aug 2026, 23:02 UTC

Humana Inc shares are lower in after-market trading, continuing a decline since Thursday's close and remaining below their 20-day moving average.

5 aug 2026, 19:56 UTC

News

Social Media

Morgan Stanley upgraded Humana Inc to Equal-Weight and raised its price target to $370. Shares are gaining amid positive analyst sentiment and service area expansion.

4 aug 2026, 20:04 UTC

News

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, raising concerns among investors and contributing to a decline in shares.

3 aug 2026, 22:26 UTC

Humana Inc. shares are higher in after-market trading, continuing gains since Monday's close, though still below the 20-day moving average.

31 jul 2026, 19:36 UTC

News

Humana Inc shares are lower today amid broader weakness in the Managed Health Care sector, despite price target increases from TD Cowen and Barclays.

30 jul 2026, 18:36 UTC

News

Upgrades from Guggenheim, Evercore ISI boost Humana investor sentiment.

29 jul 2026, 23:06 UTC

Humana Inc shares are trading lower in after-market hours, continuing a decline below the 20-day moving average and near the one-month trading range's lower end.

28 jul 2026, 23:16 UTC

News

Social Media

Humana shares decline in after-market trading following the end of a Medicare drug subsidy program, which may raise costs for seniors and pressure insurers.

27 jul 2026, 19:16 UTC

News

Humana Inc. shares are lower as Schubert Jonckheer & Kolbe LLP investigates potential false statements about healthcare costs amid ongoing securities fraud claims.

24 jul 2026, 19:31 UTC

Humana Inc's shares are lower today amid broader weakness in the Managed Health Care sub-sector, reversing a trend of higher daily closes since Thursday.

22 jul 2026, 19:26 UTC

Humana Inc. shares are lower today amid notable volatility and a mixed performance in global markets, with U.S. indices generally declining.

20 jul 2026, 18:46 UTC

Humana Inc's shares are higher today, reflecting a slight increase since Friday's close. The stock is near the upper end of its one-month trading range.

Peer Vergelijking

Prijswijziging

Humana Inc Prognose

Koersdoel

By TipRanks

11.85% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 429.86 USD 11.85%

Hoogste 624 USD

Laagste 280 USD

Gebaseerd op 23 Wall Street-analisten die 12-maands prijsdoelen bieden voor Humana Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

23 ratings

Buy

Hold

Sell

Gebaseerd op 23 analisten die aandelenratings hebben gegeven aan Humana Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

86 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.